DR. ALEXANDRA MARLISSE ROQUE SALDANA
Prescription History 1649697921
Psychiatry & Neurology - Psychiatry in San Juan, PR
NPI Status: Active since March 25, 2014
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions DR. ALEXANDRA MARLISSE ROQUE SALDANA has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Buspirone Hcl
- Specialty
- Psychiatry & Neurology
- Times Prescribed
- 11
- Number of 30-Day Refills Prescribed
- 19
- What is this prescription used for?
- This medication is used to treat anxiety. It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters).
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.